About this trial
In addition to evaluating treatment outcomes, tissue samples and swabs will be collected as part of this study to allow physicians to better understand Extramammary Paget's Disease (EMPD). The researchers also want to learn more about the microorganisms (microbiome) that live on or near the areas of skin affected by EMPD, in order to better understand this condition.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Females
Age 18 years or older
Diagnosed with primary or recurrent EMPD of vulva and/or perianal region of the body
Willing and able to provide signed informed consent
Disqualifiers
Males
Diagnosis of Paget's Disease in body areas other than vulvar or perianal region
Trial population
Women diagnosed with Extramammary Paget's Disease
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Collect prospective data including outcomes and long-term survival in women with extramammary Paget's disease (EMPD).
Prospective data including patient demographic information, surgical outcomes, surgical morbidity, recurrence, and long-term survival in extramammary Paget's disease (EMPD) will be collected as part of this registry..
Sponsors and contacts
Click on the lead sponsor to view all of their trials.